Autologous cord blood vs individualized supplements in autistic spectrum disorder: CORDUS study results

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

160

Figures (1-3)

Tables (1-1)

Sum=231

Publishing Process of This Article

Item

Count

Browse

Download

Sum=54

Mar 9, 2025 (publication date) through Dec 31, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Pediatr. Mar 9, 2025; 14(1): 96643
Published online Mar 9, 2025. doi: 10.5409/wjcp.v14.i1.96643

Table 1 Correlation of psychometric score improvement with initial markers

Correlation of psychometric score improvement	C-reactive protein (initial)	erythrocyte sedimentation rate (initial)	Tumor necrosis factor-alpha (initial)	α-2 globulins (initial)	Ferritin (initial)	Neuronal specific enolase (initial)	Total nucleated cell count/kg	CD34⁺/kg
Rho coefficient	-0.34	- 0.63	-0.53	-0.4	-0.57	0.4	0.08	0.53

Citation: Stancioiu FA, Bogdan R, Ivanescu B, Dumitrescu R. Autologous cord blood vs individualized supplements in autistic spectrum disorder: CORDUS study results. World J Clin Pediatr 2025; 14(1): 96643
URL: https://www.wjgnet.com/2219-2808/full/v14/i1/96643.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i1.96643